Ironwood Pharmaceuticals, Inc. - Class A Common Stock (NQ:IRWD)
3.360
-0.430
(-11.35%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 25, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 11,572,780 |
| Open | 3.600 |
| Bid (Size) | 3.280 (4,000) |
| Ask (Size) | 3.450 (200) |
| Prev. Close | 3.790 |
| Today's Range | 2.950 - 3.630 |
| 52wk Range | 0.5271 - 5.780 |
| Shares Outstanding | 160,028,388 |
| Dividend Yield | N/A |
Top News
More NewsPerformance
More News
Read MoreFrequently Asked Questions
Is Ironwood Pharmaceuticals, Inc. - Class A Common Stock publicly traded?
Yes, Ironwood Pharmaceuticals, Inc. - Class A Common Stock is publicly traded.
What exchange does Ironwood Pharmaceuticals, Inc. - Class A Common Stock trade on?
Ironwood Pharmaceuticals, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ironwood Pharmaceuticals, Inc. - Class A Common Stock?
The ticker symbol for Ironwood Pharmaceuticals, Inc. - Class A Common Stock is IRWD on the Nasdaq Stock Market
What is the current price of Ironwood Pharmaceuticals, Inc. - Class A Common Stock?
The current price of Ironwood Pharmaceuticals, Inc. - Class A Common Stock is 3.360
When was Ironwood Pharmaceuticals, Inc. - Class A Common Stock last traded?
The last trade of Ironwood Pharmaceuticals, Inc. - Class A Common Stock was at 02/25/26 04:00 PM ET
What is the market capitalization of Ironwood Pharmaceuticals, Inc. - Class A Common Stock?
The market capitalization of Ironwood Pharmaceuticals, Inc. - Class A Common Stock is 537.70M
How many shares of Ironwood Pharmaceuticals, Inc. - Class A Common Stock are outstanding?
Ironwood Pharmaceuticals, Inc. - Class A Common Stock has 538M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.